Indian Celecoxib Exporters: Complete Supplier Ranking with Market Share — 326 Manufacturers (2026) — TransData Nexus

Q: Who is the largest celecoxib supplier from India?

UMEDICA LABORATORIES PRIVATE LIMITED is the largest celecoxib exporter from India with a 18.6% market share and export value of $24.8M.

Q: How many celecoxib suppliers are there in India?

There are 326 active celecoxib exporters in India, collectively shipping $133.6M worth of celecoxib across 4,880 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top celecoxib suppliers from India?

The top 5 celecoxib suppliers from India — UMEDICA LABORATORIES PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED, CIPLA LIMITED, MICRO LABS LIMITED — together control 55.8% of total celecoxib export value from India.

Suresh Sormare

Celecoxib

India Pharmaceutical Trade Intelligence

$133.6M326 Suppliers112 CountriesHS 30049069

ExportsIndia → UNITED STATES49.9%India → PHILIPPINES10.2%

ImportsGERMANY → India$50.3M FRANCE → India$57.8K

#1 Supplier: UMEDICA LABORATORIES #1 Buyer: LIFESCIENCE LOGISTICS

Celecoxib Suppliers from India (2026) — 326 Exporters, $133.6M Market | TransData Nexus | TransData Nexus

Who Exports Celecoxib from India — 326 Suppliers Behind a $133.6M Market

India's celecoxib export market is supplied by 326 active exporters who collectively shipped $133.6M across 4,880 shipments. UMEDICA LABORATORIES PRIVATE LIMITED leads with a 18.6% market share, followed by MACLEODS PHARMACEUTICALS LTD and ALEMBIC PHARMACEUTICALS LIMITED. The top 5 suppliers together control 55.8% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Celecoxib Suppliers & Exporters — 326 manufacturers, $133.6M export market, top destinations and formulations — Celecoxib supplier data — 326 exporters · $133.6M market · 4,880 shipmentsTransData Nexus · Indian Customs Data

Top Celecoxib Exporters from India — Ranked by Export Value

UMEDICA LABORATORIES PRIVATE LIMITED is the leading celecoxib exporter from India, holding a 18.6% share of the $133.6M market across 4,880 shipments from 326 exporters. The top 5 suppliers — UMEDICA LABORATORIES PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED, CIPLA LIMITED, MICRO LABS LIMITED — collectively control 55.8% of total export value, indicating a moderately concentrated market. Individual shares are: UMEDICA LABORATORIES PRIVATE LIMITED (18.6%), MACLEODS PHARMACEUTICALS LTD (13.9%), ALEMBIC PHARMACEUTICALS LIMITED (9.1%), CIPLA LIMITED (9.1%), MICRO LABS LIMITED (5.1%).

Top Celecoxib Exporters from India

Ranked by export value · 326 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Celecoxib Exporters from India — Ranked by Export Value. 326 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Celecoxib — Export Intelligence Video

Visual overview of India's celecoxib supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's celecoxib pharmaceutical supplier landscape — $133.6M in total trade, 326 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Celecoxib exporters

Certification and compliance status for top Celecoxib suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Alembic Pharmaceuticals Limited	Approved	Yes (July 2025)	Unknown	223	Received multiple FDA approvals between 2024 and 2025; WHO-GMP certified as of J
Zydus Lifesciences Limited	Approved	Unknown	Unknown	Unknown	Received FDA approval for enzalutamide tablets in October 2024.
Emcure Pharmaceuticals Limited	Warning Letter (January 2	Unknown	Unknown	Unknown	Received FDA warning letter for Hinjawadi facility in January 2022.
Intas Pharmaceuticals Limited	Approved	Unknown	Unknown	89	Accord Healthcare, a subsidiary, has 89 FDA-approved ANDAs as of August 2018.

TransData Nexus reviewed the regulatory standing of 4 leading Celecoxib exporters from India. 3 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Celecoxib sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredient (API) manufacturing. The city's well-established infrastructure, coupled with a skilled workforce and supportive government policies, has attracted numerous pharmaceutical companies specializing in API production. This concentration facilitates efficient production and distribution of APIs like Celecoxib, ensuring a robust supply chain for both domestic and international markets.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies such as Alembic Pharmaceuticals, headquartered in Vadodara, have a significant presence in this region. Alembic Pharmaceuticals, established in 1907, manufactures and markets a wide range of pharmaceutical products, including APIs and formulations. The company's extensive experience and infrastructure in the region contribute to the efficient production and export of formulations like Celecoxib.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. Mumbai, being a major port city, provides logistical advantages for companies exporting pharmaceuticals. Cipla Limited, headquartered in Mumbai, is a prominent player in the pharmaceutical industry. Founded in 1935, Cipla focuses on developing medications for various medical conditions, including arthritis, which Celecoxib is commonly used to treat. The company's strategic location facilitates efficient export operations, contributing to the significant share of Celecoxib exports to destinations like the United States.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Celecoxib exporters from India

March 2023

M&A

Alembic Pharmaceuticals Limited — Alembic Pharmaceuticals merges with Aleor Dermaceuticals

Alembic Pharmaceuticals Limited completed the amalgamation of Aleor Dermaceuticals Limited, following approval from the National Company Law Tribunal, Ahmedabad Bench. - IMPACT: This merger is expected to enhance Alembic's dermatology portfolio, potentially influencing its overall export capabilities, including Celecoxib.

Impact: This merger is expected to enhance Alembic's dermatology portfolio, potentially influencing its overall export capabilities, including Celecoxib.

January 2025

M&A

Cipla Limited — Cipla acquires Ivia Beaute’s personal care brands

Cipla Limited acquired the distribution and marketing business of Ivia Beaute Pvt Ltd for ₹130 crore, with an additional ₹110 crore as milestone-based consideration, aiming to expand its consumer health vertical. - IMPACT: While this acquisition focuses on consumer wellness, it may allow Cipla to reallocate resources, potentially affecting its pharmaceutical exports, including Celecoxib.

Impact: While this acquisition focuses on consumer wellness, it may allow Cipla to reallocate resources, potentially affecting its pharmaceutical exports, including Celecoxib.

Common Questions — Celecoxib Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which celecoxib supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, UMEDICA LABORATORIES PRIVATE LIMITED leads with 65 recorded shipments worth $24.8M. MACLEODS PHARMACEUTICALS LTD (184 shipments) and ALEMBIC PHARMACEUTICALS LIMITED (434 shipments) are also established high-volume exporters.

Q How many celecoxib manufacturers are there in India?

India has 326 active celecoxib exporters with a combined export market of $133.6M across 4,880 shipments to 112 countries. The top 5 suppliers hold 55.8% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for celecoxib from India?

Average FOB unit price: $4.39 per unit, ranging from $0.00 to $730.67. Average shipment value: $27.4K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Celecoxib

Celecoxib

Who Exports Celecoxib from India — 326 Suppliers Behind a $133.6M Market

Top Celecoxib Exporters from India — Ranked by Export Value

Top Celecoxib Exporters from India

Related Analysis

Need Details?

Celecoxib — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Alembic Pharmaceuticals Limited — Alembic Pharmaceuticals merges with Aleor Dermaceuticals

Cipla Limited — Cipla acquires Ivia Beaute’s personal care brands

Common Questions — Celecoxib Suppliers from India

Q Which celecoxib supplier from India is the most reliable for bulk orders?

Q How many celecoxib manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for celecoxib from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Akums Drugs and Pharmaceuticals Limited — Akums Drugs and Pharmaceuticals goes public

Analysis Methodology